WASHINGTON – In a post on his Truth Social platform, Trump said imported generic medicines would remain exempt from tariffs until August 2028. After that, they would face a 100 percent tariff for one year, before the rate increases to 200 percent.
Trump said the two-year grace period would give pharmaceutical companies sufficient time to relocate production of generic drugs to the United States.
He also warned that companies choosing not to establish manufacturing facilities in the US would face penalties, although he did not specify what those penalties would be or outline the legal basis for imposing the proposed tariffs.
The announcement is expected to increase pressure on pharmaceutical manufacturers that currently produce generic medicines outside the United States.
Read More
- Kuwait repels attacks by hostile drones
- Scientists warn of Great Barrier Reef collapse risk amid severe coral bleaching
- Japan warns of dangerous heatwave as temperatures reach record levels
- 27 bodies recovered after Guyana ferry disaster; 83 still missing
- UAE sends 70 tonnes of humanitarian aid to Venezuela following twin earthquakes
